𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Living donor liver transplantation for hepatitis C related hepatocellular carcinoma in a haemophilia A patient

✍ Scribed by W. Y. Au; C. L. Liu; C. M. Lo; S. T. Fan; C. K. Lam

Book ID
108772401
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
43 KB
Volume
11
Category
Article
ISSN
1351-8216

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

De novo hepatocellular carcinoma in a li
De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation
✍ Kazutoyo Morita; Akinobu Taketomi; Yuji Soejima; Toru Ikegami; Takasuke Fukuhara πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 276 KB πŸ‘ 1 views

The occurrence of de novo hepatocellular carcinoma (HCC) after liver transplantation (LT) for advanced HCCs has been extremely limited. In this article, a case of de novo HCC in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation (LDLT) for multiple HCCs

Living donor liver transplantation for h
Living donor liver transplantation for hepatocellular carcinoma: A single-center preliminary report
✍ Massimo MalagΓ³; Georgios C. Sotiropoulos; Silvio Nadalin; Camino Valentin-Gamazo πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 100 KB

Liver transplantation (LT) is the treatment of choice for early hepatocellular carcinoma (HCC) in patients with end-stage liver disease but is limited by the availability of donor organs. Living donor liver transplantation (LDLT) represents an alternative therapeutic option for patients with disease

Liver transplantation for adult patients
Liver transplantation for adult patients with hepatocellular carcinoma in Korea: Comparison between cadaveric donor and living donor liver transplantations
✍ Shin Hwang; Sung-Gyu Lee; Jae-Won Joh; Kyung-Suk Suh; Dong-Goo Kim πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 202 KB πŸ‘ 2 views

Current selection criteria of liver transplantation (LT) for patients with hepatocellular carcinoma (HCC) were derived from the outcomes of cadaveric donor LT (CDLT). We tried to assess the applicability of such criteria to living donor LT (LDLT) through a comparative study between CDLT and LDLT. We

Living donor liver transplantation as a
Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma
✍ Yasutsugu Takada; Mikiko Ueda; Takashi Ito; Seisuke Sakamoto; Hironori Haga; Yoj πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 220 KB πŸ‘ 1 views

Living donor liver transplantation (LDLT) has evolved to represent an important surgical strategy for patients with hepatocellular carcinoma (HCC). However, due to disadvantages, including donor risks and higher rates of perioperative complications, LDLT has been considered as a second-line treatmen